Stifel Nicolaus Initiates Biotie Therapies At Buy
July 06, 2015 at 09:34 AM EDT
Analysts at Stifel Nicolaus initiated coverage on Biotie Therapies Oyj (ADR) (NASDAQ: BITI) with a Buy rating. The target price for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.